Our research
In Western countries, one in two men and one in three women will develop a tumor disease in the course of their lives. In Germany, too, the number of people diagnosed with cancer each year remains alarmingly high. In 2020 alone, more than 600,000 new cases of cancer were diagnosed in Germany and over 250,000 patients died from cancer. Almost all types of cancer occur much more frequently
in older people than in younger people. Therefore, a further increase in cancer rates can be expected in the coming years due to increased life expectancy. At the Georg-Speyer-Haus, Institute of Tumor Biology and Experimental Therapy, we are investigating the molecular and cellular basis of tumor development with the aim of finding new approaches for cancer therapy. In particular, we focus on the analysis and interaction of the different cell types in tumor tissue in the so-called tumor microenvironment.
Together with the Department of Medicine at Goethe University and the University Hospital, we are the founding bodies of the University Center for Tumor Diseases (UCT). We cooperate closely in the LOEWE Center Frankfurt Cancer Institute (FCI) as well as the German Consortium for Translational Cancer Research (DKTK). This excellent collaboration allows us to rapidly evaluate our basic research results in clinical trials and thus to make our knowledge available to patients.
Our research areas
Tumormicroenvironment – Pathogenesis and Target Structures
Read more on the pages of Prof. Dr. Arkan, Dr. Farin, Prof. Dr. Greten und Dr. Medyouf.
Experimentelle Therapie
Read more on the pages of Dr. Grote, Dr. Tatarova, Dr. Tichet und Prof. Dr. Wels
Our current annual report gives you an overview of our ongoing activities and the current state of research with us at the Institute of Tumor Biology and Experimental Therapy.
Do you want to work with us? You can find all the information you need on our careers page.